HEALTH● LOW1h ago · Oct 19, 2026, 11:45 AM
Tonix Pharmaceuticals to Present an Analysis of Phase 3 Data on TONMYA® at the IASP 2026 World Congress on Pain
manilatimes.net · Philippines · global
Tonix Pharmaceuticals is scheduled to present an analysis of its Phase 3 data for TONMYA® at the IASP 2026 World Congress on Pain. This highlights upcoming developments in pharmaceutical research for pain management.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapPhilippines and nearby eventsMore from PhilippinesLatest stories and threat level
More from Philippines
SCI & TECH3h agoIs Philippines’ laws on underwater cables lagging behind its digital hub goal?South China Morning PostPOLITICS9h agoUnrest in Philippines threatens to upend US backed data centersResponsible StatecraftBUSINESS2d agoSolar power booms in Philippines as war on Iran spikes energy costsAl Jazeera [en]POLITICS2d agoPhilippines’ ‘China-free’ manufacturing strategy is a high-risk betSouth China Morning Post
More in Health
HEALTH32m agoEbola: Kenya confirms eighth case as DRC outbreak reaches new provinceEuroNews [en]HEALTH1h agoThe multiple sclerosis gap Europe cannot afford to ignorePolitico EuropeHEALTH1h agoObesity: Saving can become expensive for the statePolitico EuropeHEALTHBREAKING1h agoThird Ebola case in Kenya highlights US failures amid Trump cuts to key servicesGuardian World